CFLT vs OBIO · rev $963.6M vs rev $2.6M
Confluent Inc (CFLT) versus Orchestra BioMed Holdings Inc. (OBIO) — a side-by-side from cached financials, not a winner call.
Confluent Inc (CFLT) is a software - infrastructure company listed on US.
Orchestra BioMed Holdings Inc. (OBIO) is a biotechnology company listed on NASDAQ.
Latest reported CFLT revenue for 2024-12-31 was $963.6M. Net income was -$345.1M. Revenue was up 24.0% from 2023-12-31 to 2024-12-31. CFLT currently screens at market cap $11.13B.
Latest reported OBIO revenue for 2024-12-31 was $2.6M. Net income was -$61.0M. Revenue was down 4.4% from 2023-12-31 to 2024-12-31. OBIO currently screens at market cap $231.7M.
CFLT currently screens at market cap $11.13B. OBIO currently screens at market cap $231.7M.
Not investment advice. Open the CFLT and OBIO stock pages for the full models.
Not investment advice.